Volume 112, Issue 1 pp. 61-70
Cancer Cell Biology

αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma

Pekka Koistinen

Pekka Koistinen

MediCity Research Laboratory, University of Turku, Turku, Finland

Department of Medical Biochemistry, University of Turku, Turku, Finland

Turku Graduate School of Biomedical Sciences, University of Turku, Turku, Finland

Search for more papers by this author
Matti Ahonen

Matti Ahonen

Center for Biotechnology, University of Turku, Turku, Finland

Search for more papers by this author
Veli-Matti Kähäri

Veli-Matti Kähäri

Department of Medical Biochemistry, University of Turku, Turku, Finland

Center for Biotechnology, University of Turku, Turku, Finland

Department of Dermatology, University of Turku, Turku, Finland

Search for more papers by this author
Jyrki Heino

Corresponding Author

Jyrki Heino

MediCity Research Laboratory, University of Turku, Turku, Finland

Department of Medical Biochemistry, University of Turku, Turku, Finland

Fax: +358-2-3337000

MediCity Research Laboratory, University of Turku, Tykistökatu 6A, FIN-20520 Turku, FinlandSearch for more papers by this author
First published: 02 June 2004
Citations: 40

Abstract

The expression of integrin αV subunit on 4 melanoma-derived cell lines (A2058, SK-mel-5, WM-115 and WM-266-4) was analyzed. WM-115 cells, which originate from a primary tumor, were negative, whereas all 3 metastasis-derived lines had high levels of αV. To study αV integrins in the survival of melanoma cells, we developed a novel strategy that is exempt from extracellular inhibitors of ligand binding, which can activate integrin signaling and have integrin-independent effects on apoptosis. A recombinant adenovirus was used to transfer cDNA coding for a single-chain intracellular anti-αV integrin antibody into the melanoma cells. Anti-αV integrin adenovirus effectively inhibited the cell surface expression of αV integrins. In cell culture experiments, the depletion of αV integrins detached cells from extracellular matrix and induced apoptosis. Moreover, it prevented WM-266-4 cells from forming tumors in severe combined immunodeficiency mice but it could not prevent the growth of tumors that were formed by αV-negative WM-115 cells. Our results indicate that in primary melanomas there are cells that survive without αV integrins, whereas during the progression of disease cells can develop a dependency on these receptors. Furthermore, the data oppose the possibility that in melanoma cells apoptosis could occur due to direct activation of caspases by ligand-free αV integrins on the cell surface. © 2004 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.